Brief: Jupiter Neurosciences Announces First Patient Dosed In Phase 2A Reset Trial In Parkinson’S Disease
06/10/2026 16:35
BRIEF-Jupiter Neurosciences Announces First Patient Dosed In Phase 2A Reset Trial In Parkinson’S Disease Oct 6 (Reuters) - Jupiter Neurosciences Inc JUNS.O:
JUPITER NEUROSCIENCES ANNOUNCES FIRST PATIENT DOSED IN PHASE 2A RESET TRIAL IN PARKINSON’S DISEASE AND EXPLORATION OF STRATEGIC OPTIONS TO MAXIMIZE SHAREHOLDER VALUE
JUPITER NEUROSCIENCES - INITIATES FORMAL PROCESS TO EXPLORE STRATEGIC OPTIONS
Source text: ID:nGNXWn5F9
Further company coverage: JUNS.O
((Reuters.Briefs@thomsonreuters.com;))